Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
about
How to predict clinical relapse in inflammatory bowel disease patientsMesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?Frequency and significance of granulomas in a cohort of incident cases of Crohn's diseaseElevated serum values of procollagen III peptide (PIIIP) in patients with ulcerative colitis who will develop pseudopolyps.C-reactive protein levels during a relapse of Crohn's disease are associated with the clinical course of the disease.Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet's disease.Analysis of biological variables in Crohn's disease.Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.How often do patients with IBD have symptom recurrence?Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.Outcome predictors for thiopurine maintenance therapy in patients with Crohn's disease.
P2860
Q26774575-9C4EFD8B-2C4F-4A69-8CAA-53DC58766D64Q33617826-FD084EB5-DD99-4D7D-A443-21F5335AA9E1Q33879437-FC36A995-2575-4132-BE0E-A3009036B455Q34564902-98755411-DEF3-4668-B536-5A5AF72D8DF5Q34609407-8B839618-1437-458D-8ECE-B851957022F3Q35598130-D01979A1-2D68-4C8C-BB4F-EA9C00B713A5Q36209801-3DE56280-595A-45C3-8004-59F546C7950EQ37169735-AE67354C-3D15-48CC-B536-198BC0A8AB97Q41981253-6D90AD4D-7460-43CE-A97F-81D91C334361Q43120103-C3BB0030-A036-4005-A1AE-FFC79115919DQ43749263-8FE12022-81E6-4AA6-9734-84D94768A645Q44372471-FB9944A1-A65E-4321-99CC-6C86BC3600EBQ50757657-9DF91363-08EF-450E-9E50-D49CD4835D4CQ51392532-2C702234-FF1E-432C-8AF3-D54B62B61B10
P2860
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@ast
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@en
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@nl
type
label
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@ast
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@en
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@nl
prefLabel
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@ast
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@en
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@nl
P2093
P2860
P356
P1433
P1476
Identifying patients with a hi ...... ons Inflammatoires Digestives.
@en
P2093
Colombel JF
Hoctin-Boes G
Lerebours E
Modigliani R
Sylvester R
P2860
P304
P356
10.1136/GUT.37.6.811
P407
P577
1995-12-01T00:00:00Z